Look what just popped up on my email. I guess when I signed up for Medscape to read the piece by Dr. Lieberman about the coming lab diagnoses in Psychiatry [psychiatry inc…], I opened the door:

Which lead to this [see ought to know by now…]:

Here we go again! Guess which click here I picked?
Speaking of who to trust for reliable untainted by pharma info….
http://bipolarsoupkitchen-stephany.blogspot.com/2011/10/stanford-hosted-public-mood-disorder.html
have you read about PharmaNeuroBoost? what a scientific adviser board they have, Charles Nemeroff and Schatzberg. A bio tech co taking already patented drugs and tweaking the formula for lucrative investment returns. Schatzberg listed his stock as a disclosure on the Stanford site. Nemeroff of course knows where to follow the $$$$$$$$
I believe it is called pharmaceutical bottom fishing – for those cannot come up with something really new. Nemeroff’s CeNeRx company is another example.